Completed OBSERVATIONAL NCT05581966

Wound Assessment Using Spectral Imaging EU/UK (WAUSI EU/UK)

Wound Assessment Using Spectral Imaging

Sponsor: SpectralMD

Conditions Diabetes Diabetic Foot Diabetic Foot Ulcer

Updated 6 times since 2022 Last updated: Nov 5, 2024 Started: Mar 15, 2023 Primary completion: Jun 28, 2024 Completion: Jun 28, 2024

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Diabetes and Diabetic Foot, this trial is completed. The trial is conducted by SpectralMD and has accumulated 6 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Dec 2024 — Present [monthly]

Completed

Status: Unknown → Completed
Oct 2024 — Dec 2024 [monthly]

Unknown

Status: Not Yet Recruiting → Unknown
Sep 2024 — Oct 2024 [monthly]

Not Yet Recruiting
Jul 2024 — Sep 2024 [monthly]

Not Yet Recruiting
Apr 2023 — Jul 2024 [monthly]

Not Yet Recruiting

▶ Show 1 earlier version

Nov 2022 — Apr 2023 [monthly]

Not Yet Recruiting

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

SpectralMD

Data source: SpectralMD

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Abbotstown, Ireland